Following Transplantation for Acute Myelogenous Leukemia, Donor KIR Cen B02 Better Protects against Relapse than KIR Cen B01. Guethlein LA, Beyzaie N, Nemat-Gorgani N, Wang T, et al. J Immunol 2021 Jun 11. pii: jimmunol.2100119. doi: 10.4049/jimmunol.2100119.

Read + Share

Amedeo Smart

Independent Medical Education

Guethlein LA, Beyzaie N, Nemat-Gorgani N, Wang T, et al. Following Transplantation for Acute Myelogenous Leukemia, Donor KIR Cen B02 Better Protects against Relapse than KIR Cen B01. J Immunol 2021 Jun 11. pii: jimmunol.2100119. doi: 10.4049/jimmunol.2100119.
PMID: 34117109